Radiotherapy for localized rectal cancer

Ann Oncol. 2007 Jul:18 Suppl 9:ix105-13. doi: 10.1093/annonc/mdm304.
No abstract available

Publication types

  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Camptothecin / analogs & derivatives
  • Camptothecin / therapeutic use
  • Capecitabine
  • Combined Modality Therapy
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy / methods
  • ErbB Receptors / antagonists & inhibitors
  • Fluorouracil / analogs & derivatives
  • Fluorouracil / therapeutic use
  • Humans
  • Irinotecan
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Preoperative Care
  • Radiotherapy Dosage
  • Radiotherapy, Conformal / adverse effects
  • Randomized Controlled Trials as Topic
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Rectal Neoplasms / metabolism
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / radiotherapy*
  • Rectum / blood supply
  • Rectum / pathology*
  • Rectum / radiation effects
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Organoplatinum Compounds
  • Oxaliplatin
  • Deoxycytidine
  • Capecitabine
  • Irinotecan
  • ErbB Receptors
  • Receptors, Vascular Endothelial Growth Factor
  • Fluorouracil
  • Camptothecin